Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$176.1K
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 4 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 8 most recent Form 4 transactions.
| Open the original filing on SEC.gov |
| Jan 30 | AKBA | Akebia Therapeutics, Inc. | AGRANT◆ | 119,000 | — | — | — | Open the original filing on SEC.gov |
| Jan 30 | AKBA | Akebia Therapeutics, Inc. | AGRANT | 79,000 | — | — | +29.3% | Open the original filing on SEC.gov |
| Jun 9, 2025 | AKBA | Akebia Therapeutics, Inc. | MEXER◷◆ | 15,000 | — | — | — | Open the original filing on SEC.gov |
| Jun 9, 2025 | AKBA | Akebia Therapeutics, Inc. | SSELL◷ | 15,000 | $4.01 | $60.2K | -5.3% | Open the original filing on SEC.gov |
| Jun 9, 2025 | AKBA | Akebia Therapeutics, Inc. | MEXER◷ | 15,000 | $1.68 | $25.2K | +5.6% | Open the original filing on SEC.gov |
| Jun 4, 2025 | AKBA | Akebia Therapeutics, Inc. | SSELL◷ | 13,334 | $3.53 | $47.1K | -4.8% | Open the original filing on SEC.gov |